Toronto Dominion Bank Sells 10,977 Shares of The Clorox Company (NYSE:CLX)

Toronto Dominion Bank reduced its position in The Clorox Company (NYSE:CLX) by 16.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 54,767 shares of the company’s stock after selling 10,977 shares during the period. Toronto Dominion Bank’s holdings in Clorox were worth $8,895,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Brooklyn Investment Group grew its holdings in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares in the last quarter. Redwood Park Advisors LLC purchased a new stake in shares of Clorox in the fourth quarter valued at approximately $26,000. Millstone Evans Group LLC purchased a new position in shares of Clorox during the fourth quarter valued at $31,000. Asset Planning Inc purchased a new position in shares of Clorox in the 4th quarter valued at $32,000. Finally, GKV Capital Management Co. Inc. acquired a new stake in Clorox in the fourth quarter valued at approximately $32,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on CLX shares. Evercore ISI set a $140.00 price target on shares of Clorox and gave the stock an “underperform” rating in a research report on Tuesday, May 6th. JPMorgan Chase & Co. reduced their price objective on shares of Clorox from $151.00 to $144.00 and set a “neutral” rating for the company in a research report on Tuesday, May 6th. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Barclays dropped their target price on shares of Clorox from $134.00 to $129.00 and set an “underweight” rating for the company in a report on Wednesday, May 7th. Finally, Morgan Stanley dropped their price objective on shares of Clorox from $165.00 to $150.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 6th. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $151.23.

Clorox Trading Up 0.5%

Clorox stock opened at $135.53 on Wednesday. The stock has a 50-day moving average price of $140.57 and a 200 day moving average price of $152.97. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The stock has a market cap of $16.70 billion, a PE ratio of 37.03, a P/E/G ratio of 2.62 and a beta of 0.60. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37.

Clorox (NYSE:CLX) last posted its earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. Clorox had a return on equity of 316.87% and a net margin of 6.38%. The firm’s revenue for the quarter was down 8.0% compared to the same quarter last year. During the same period last year, the company posted $1.71 EPS. Equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 9th. Investors of record on Wednesday, April 23rd were issued a $1.22 dividend. The ex-dividend date was Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.60%. Clorox’s dividend payout ratio is presently 87.61%.

Insider Activity

In other news, Director Pierre R. Breber acquired 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 7th. The shares were purchased at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the transaction, the director now directly owns 4,000 shares in the company, valued at $546,280. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.57% of the company’s stock.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.